Patient age, the status of menopause, histological tumor size, lymph node status, tumor grade, and expression parameters for ER, PR, Her2, and Ki-67 by immunohistochemistry (IHC) were the most common prognostic factors for BC relapses. This evidence concerns the gene PGR and breast cancer.